View in EDS HTML Full Text PDF Full Text

Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.

Saved in:
Bibliographic Details
Title: Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
Authors: Rousel J; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands., Saghari M; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands., Pagan L; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands., Nădăban A; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands., Gambrah T; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands., Theelen B; Westerdijk Fungal Biodiversity Institute, 3508 AD Utrecht, The Netherlands., de Kam ML; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands., Haakman J; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands., van der Wall HEC; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands., Feiss GL; Cutanea Life Sciences, Wayne, PA 19087, USA., Niemeyer-van der Kolk T; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands., Burggraaf J; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands., Bouwstra JA; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands., Rissmann R; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands., van Doorn MBA; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Department of Dermatology, Erasmus Medical Centre, 3015 GD Rotterdam, The Netherlands.
Source: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 20; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 20.
Publication Type: Randomized Controlled Trial; Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37762625
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rousel+J%22">Rousel J</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Saghari+M%22">Saghari M</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Pagan+L%22">Pagan L</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Nădăban+A%22">Nădăban A</searchLink>; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gambrah+T%22">Gambrah T</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Theelen+B%22">Theelen B</searchLink>; Westerdijk Fungal Biodiversity Institute, 3508 AD Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Kam+ML%22">de Kam ML</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Haakman+J%22">Haakman J</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Wall+HEC%22">van der Wall HEC</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Feiss+GL%22">Feiss GL</searchLink>; Cutanea Life Sciences, Wayne, PA 19087, USA.<br /><searchLink fieldCode="AU" term="%22Niemeyer-van+der+Kolk+T%22">Niemeyer-van der Kolk T</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Burggraaf+J%22">Burggraaf J</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bouwstra+JA%22">Bouwstra JA</searchLink>; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rissmann+R%22">Rissmann R</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.; Leiden University Medical Center, Leiden University, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Doorn+MBA%22">van Doorn MBA</searchLink>; Centre for Human Drug Research, 2333 CL Leiden, The Netherlands.; Department of Dermatology, Erasmus Medical Centre, 3015 GD Rotterdam, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101092791%22">International journal of molecular sciences</searchLink> [Int J Mol Sci] 2023 Sep 20; Vol. 24 (18). <i>Date of Electronic Publication: </i>2023 Sep 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101092791 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1422-0067 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214220067%22">14220067 </searchLink><i>NLM ISO Abbreviation: </i>Int J Mol Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37762625
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/ijms241814315
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rousel J
      – PersonEntity:
          Name:
            NameFull: Saghari M
      – PersonEntity:
          Name:
            NameFull: Pagan L
      – PersonEntity:
          Name:
            NameFull: Nădăban A
      – PersonEntity:
          Name:
            NameFull: Gambrah T
      – PersonEntity:
          Name:
            NameFull: Theelen B
      – PersonEntity:
          Name:
            NameFull: de Kam ML
      – PersonEntity:
          Name:
            NameFull: Haakman J
      – PersonEntity:
          Name:
            NameFull: van der Wall HEC
      – PersonEntity:
          Name:
            NameFull: Feiss GL
      – PersonEntity:
          Name:
            NameFull: Niemeyer-van der Kolk T
      – PersonEntity:
          Name:
            NameFull: Burggraaf J
      – PersonEntity:
          Name:
            NameFull: Bouwstra JA
      – PersonEntity:
          Name:
            NameFull: Rissmann R
      – PersonEntity:
          Name:
            NameFull: van Doorn MBA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 09
              Text: 2023 Sep 20
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1422-0067
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 18
          Titles:
            – TitleFull: International journal of molecular sciences
              Type: main
ResultId 1